Development and Evaluation of Tri-Functional Immunoliposomes for the Treatment of HER2 Positive Breast Cancer. [electronic resource]
Producer: 20190606Description: 95 p. digitalISSN:- 1573-904X
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Breast Neoplasms -- drug therapy
- Cell Line, Tumor
- Delayed-Action Preparations -- administration & dosage
- Doxorubicin -- administration & dosage
- Drug Compounding -- methods
- Drug Screening Assays, Antitumor
- Female
- Humans
- Leukocytes, Mononuclear
- Liposomes
- Muromonab-CD3 -- administration & dosage
- Receptor, ErbB-2 -- metabolism
- Trastuzumab -- administration & dosage
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.